CANDACE HUDSON: Open Payments
NPI 1184733230 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$287 in 14 payments from 9 companies in 2025. Trend: 2023 $190 · 2024 $358 · 2025 $287
Food & beverage: $287
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $74 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Novo Nordisk Inc | 2 | $33 |
| Lilly USA, LLC | 1 | $29 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
Products named: VRAYLAR, SHINGRIX, BREZTRI, MOUNJARO, UBRELVY, INSPIRE, Auvelity, Wegovy.
Industry payments across MO — which companies pay providers there.
